Xcout Intel
MitoRx Therapeutics competitors & alternatives
The 12 closest competitors and alternatives to MitoRx Therapeutics among life sciences companies — ranked by similarity to what MitoRx Therapeutics actually does, not by market-cap band.
Subscribe to see MitoRx Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About MitoRx Therapeutics
MitoRx Therapeutics is a platform biotechnology company headquartered in Oxford, England, developing novel mitochondrial-targeted therapeutics for life sciences.
MitoRx Therapeutics at a glance
MitoRx Therapeutics is a life sciences company headquartered in United Kingdom. It has raised at least $7.3M across the 2 funding rounds on record, 1 of them with a disclosed amount. Its most recent funding round, Pre-Series A, raised $7.3M in December 2025. Xcout tracks 12 named people at MitoRx Therapeutics, including Alison Strutt (Chief Financial Officer).
MitoRx Therapeutics leadership
- Alison StruttChief Financial Officer
- László TankóConsultant Chief Medical Officer
- Rick CousinsChief Discovery Officer
- Xavier JacqChief Scientific Officer
- Glyn EdwardsExecutive Chairman
- Jon ReesCEO and Co-founder
6 more named people on record for MitoRx Therapeutics, with roles, board committees and tenure — see the full roster →
MitoRx Therapeutics funding rounds
At least $7.3M raised across the 2 rounds on record (1 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Pre-Series A | $7.3M | 1 named | |
| — | Undisclosed | 3 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 MitoRx Therapeutics competitors
Ranked by semantic similarity — how close each company is to MitoRx Therapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Mitotherapeutix, LLC is a biotechnology company that develops small interfering RNA (siRNA) based therapeutics targeting difficult disease pathways. The company focuses on modulating mitochondrial metabolic activity by inhibiting a negative gene regulator to treat a wide array of diseases.
Biotechnology
Cellvie AG is a biotechnology company based in Zurich, Switzerland, pioneering Therapeutic Mitochondria Transplantation to target cellular energy metabolism.
Biotech
ScandiBio Therapeutics is a clinical-stage biotechnology company headquartered in Stockholm, Sweden, founded to develop pharmaceutical drugs targeting mitochondrial dysfunction.
Biotech
Abliva is a company headquartered in Lund, Sweden, focused on delivering mitochondrial health. It leverages in-house R&D capabilities to create a portfolio of projects with various mechanisms of action.
Biotech
Pretzel Therapeutics is a biotechnology company headquartered in Boston, Massachusetts, advancing a new class of medicines that target cellular energetics and mitochondrial function.
Biotechnology
Paean Holdings, Inc. (operating as PAEAN Biotechnology) develops mitochondria-based therapeutics designed to treat rare diseases, inflammatory conditions, cancer, and central nervous system disorders. The company utilizes proprietary platforms including mitochondrial transplantation, modified mitochondria for targeted delivery, and mitochondria-augmented cell therapy to address critical medical needs and overcome cellular metabolic limitations.
Biotechnology
NanoSyrinx Ltd. is a biotechnology company incorporated in England and Wales with headquarters in Warwick, focused on advancing targeted drug delivery platforms.
Biotechnology
Myricx Bio is a UK biotech company headquartered in London. It specializes in the discovery and development of a novel class of selective cytotoxic payloads for Antibody-Drug Conjugates (ADCs).
Biotechnology
Sironax is a biopharmaceutical company committed to developing new treatments by targeting underlying contributors of degeneration, including neurodegenerative, inflammatory, and metabolic disorders.
Biotechnology
Vandria is a biotechnology research company founded in September 2021 and based at the Biopôle campus in Epalinges, Switzerland. The company specializes in discovering first-in-class small molecules targeting mitochondrial function to treat age-related diseases. It operates with a small team focused on novel metabolic pathways.
Similar life sciences company
Curve Therapeutics is a private biotechnology company headquartered in Southampton, United Kingdom, pioneering a revolutionary proprietary microcycle drug discovery platform to address challenging intracellular targets.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of MitoRx Therapeutics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for MitoRx Therapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →